Related references
Note: Only part of the references are listed.Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
Teresa A. Allison et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2020)
Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
Jennifer A. Frontera et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
Melanie N. Smith et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Independent Validation of the Hematoma Expansion Prediction Score: A Non-contrast Score Equivalent in Accuracy to the Spot Sign
Vignan Yogendrakumar et al.
NEUROCRITICAL CARE (2019)
Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo
Harry Peled et al.
CHEST (2019)
Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage
Daniel Dybdahl et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Andexanet alfa-The first 150 days
Sarah E. Culbreth et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate
Marwan Sheikh-Taha
INTERNAL AND EMERGENCY MEDICINE (2019)
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
Adam Cuker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis
Siavash Piran et al.
BLOOD ADVANCES (2019)
Association of Prothrombin Complex Concentrate Administration and Hematoma Enlargement in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage
Stefan T. Gerner et al.
ANNALS OF NEUROLOGY (2018)
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
Jing Tao et al.
JOURNAL OF INTENSIVE CARE (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Daniel M. Witt et al.
BLOOD ADVANCES (2018)
Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage
Jessica L. Corio et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2018)
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Maureane Hoffman et al.
INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE (2018)
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Gordon F. Tomaselli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Reversal of Oral Anticoagulants for Intracerebral Hemorrhage Patients: Best Strategies
Lanting Fuh et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents
Thorsten Steiner et al.
STROKE (2017)
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Ammar Majeed et al.
BLOOD (2017)
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Jennifer A. Frontera et al.
NEUROCRITICAL CARE (2016)
Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis
Chatree Chai-Adisaksopha et al.
THROMBOSIS AND HAEMOSTASIS (2016)
New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series
Sebastian Senger et al.
WORLD NEUROSURGERY (2016)
Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage
Gregoire Boulouis et al.
JAMA NEUROLOGY (2016)
Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors
Ramesh Grandhi et al.
WORLD NEUROSURGERY (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
Antonio Gomez-Outes et al.
THROMBOSIS RESEARCH (2014)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes
Dar Dowlatshahi et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
Systematic Characterization of the Computed Tomography Angiography Spot Sign in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk for Hematoma Expansion The Spot Sign Score
Josser E. Delgado Almandoz et al.
STROKE (2009)
Determinants of intracerebral hemorrhage growth - An exploratory analysis
Joseph P. Broderick et al.
STROKE (2007)
Share Paper
